Market Research Future (MRFR) has published a cooked research report on the “Global Painkiller Market” that contains information from 2018 to 2032. The Painkiller market is estimated to register a CAGR of 4.20% during the forecast period of 2023 to 2032.

Painkiller Market Highlights

The global Painkiller market is accounted to register a CAGR of 4.20% during the forecast period and is estimated to reach USD 100.6 billion by 2032.

The painkiller market is growing due to factors such as an aging population, increasing prevalence of chronic pain conditions, and advancements in pharmaceutical research. The demand for effective pain management solutions, coupled with a rise in healthcare awareness, contributes to market growth. Additionally, the availability of over-the-counter painkillers and the development of novel analgesic medications further drive the expansion of the painkiller market, meeting the diverse needs of consumers seeking relief from various pain-related issues.

Key Players

MRFR recognizes the following companies as the key players in the global Painkiller market— Pfizer Inc., Johnson & Johnson, Novartis AG, GlaxoSmithKline plc, Bayer AG, Eli Lilly and Company, Sanofi S.A., Merck & Co., Inc., AstraZeneca plc, Teva Pharmaceutical Industries Ltd.

Segment Analysis

The global Painkiller market has been segmented based Drug Class, Product, Indication, Route of Administration and Distribution Channel.

On the basis of drug class, the market is segmented into Opioids, Tramadol, Oxycodone, Hydrocodone, Other Opioids, NSAIDs, Local Anesthetics and Acetaminophen. The Local anesthetics, as a drug class, have captured the largest market share in the painkiller market in 2022, due to their widespread use in various medical procedures and surgeries.

Based on product, the global Painkiller market has been segmented into OTC Products and Prescription Drugs. The OTC products have secured the largest market share in the painkiller market in 2022, due to their accessibility and widespread consumer use.

Based on indication, the global Painkiller market has been segmented into Surgical Pain, Cancer Pain, Neuropathic Pain, Musculoskeletal and Joint Pain and Others. The surgical pain indication has captured the largest market share in the painkiller market in 2022, due to the prevalence of surgical procedures requiring effective postoperative pain management.

Based on route of administration, the global Painkiller market has been segmented into Injectable, Oral, Rectal, Topical, Transdermal and Others. The oral route of administration has secured the largest market share in the painkiller market in 2022, due to its convenience, patient preference, and ease of administration.

Based on distribution channel, the global Painkiller market has been segmented into Hospital Pharmacies, Specialty Clinics, Long-Term Care Centers, Retail Pharmacies, Drug Stores and Online Pharmacies. The hospital pharmacies have captured the largest market share in the painkiller market in 2022, due to their role as major healthcare hubs where a wide range of painkillers are dispensed.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Painkiller Market Research Report

Regional Analysis

The global Painkiller market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Painkiller market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Painkiller market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Painkiller market comprises of Middle East, Africa, and Latin America.

The largest market share for Painkiller was maintained by the North American regional sector. North America has secured the largest market share in the painkiller market due to several factors. The region experiences a high prevalence of chronic pain conditions, contributing to substantial demand for pain management solutions. Additionally, well-established healthcare infrastructure, a strong emphasis on pain relief, and the availability of a wide range of painkillers contribute to North America's dominance. Stringent regulations and the ongoing response to the opioid crisis also shape the painkiller market landscape in this region.

Moreover, the Europe market has been persistently growing over the forecast period. Europe has captured the second-largest market share in the painkiller market due to its well-developed healthcare systems, increasing awareness of pain management, and a high incidence of chronic pain conditions. The region's stringent regulatory framework ensures responsible prescribing practices, influencing the market landscape. Additionally, the growing aging population and advancements in medical treatments contribute to the demand for painkillers. Europe's focus on patient care and adherence to safety standards positions it as a significant market player in pain management.

The Asia Pacific region is experiencing the highest Compound Annual Growth Rate (CAGR) in the painkiller market due to factors such as a rising population, increasing healthcare awareness, and a growing prevalence of chronic diseases. As healthcare infrastructure improves and access to medical services expands, the demand for pain management solutions surges. Additionally, changing lifestyles and an aging population contribute to the escalating need for painkillers in the Asia Pacific region, driving its notable CAGR in the painkiller market.

Furthermore, the rest of the world's Painkiller market is divided into the Middle East, Africa, and Latin America. The rest of the world is experiencing growth in the painkiller market due to increasing healthcare access, rising awareness of pain management, and a growing incidence of chronic diseases. The expansion of pharmaceutical markets, advancements in healthcare infrastructure, and evolving consumer preferences contribute to the market's global growth.

Key Findings of the Study

• The global Painkiller market is expected to reach USD 100.6 billion by 2032, at a CAGR of 4.20% during the forecast period.


• The Asia Pacific region is the fastest-growing in the painkiller market due to a growing population, increasing healthcare awareness, and rising incidence of chronic pain conditions. Expanding healthcare infrastructure and pharmaceutical markets contribute to the region's rapid market growth.


• Based on distribution channel, the hospital pharmacies segment was attributed to holding the largest market in 2022, with an approximate market share of 20–25%.


• Pfizer Inc., Johnson & Johnson, Novartis AG, GlaxoSmithKline plc, Bayer AG, Eli Lilly and Company, Sanofi S.A., Merck & Co., Inc., AstraZeneca plc, Teva Pharmaceutical Industries Ltd.